PharmTech News

Articles

Exscientia has entered into a binding agreement to acquire the artificial intelligence precision-based medicines company, Allcyte.

Exscientia Enters Binding Agreement to Acquire Allcyte

Evonik and Stanford University have signed a research collaboration to develop and market a new drug delivery platform for mRNA and gene therapy.

Evonik and Stanford University Partner to Develop mRNA Drug Delivery Technology

Yposkesi is building its second commercial facility for cell and gene therapy manufacturing at its campus on Corbeil-Essonnes, France.

Yposkesi Launches Project SKY for its Second Commercial Bioproduction Site

Optima has teamed up with the Robert-Bosch-Krankenhaus and Heidelberg University to develop a unit for decentralized, automated production of CAR-T cell therapies.

Optima Teams Up with Clinics to Develop Production Unit for CAR-T Cell Therapies

CPI has revealed an agreement with DFE Pharma, making it the latest partner of the Medicines Manufacturing Innovation Centre (MMIC) collaboration.

DFE Pharma Becomes Newest Partner in MMIC Collaboration

Immodulon has received an indication of allowability from the European Patent Office for the claims in its patent application relating to its lead drug candidate.

Immodulon Gains Allowability of Claims for Key European Patent Application

Roambee has acquired Modum, a Swiss pharma last mile-focused cold chain monitoring player, expanding its cold chain visibility capabilities.

Roambee Expands Cold Chain Visibility Offering Through Modum Acquisition

Brinter has successfully closed a €1.2 million (US $1.5 million) seed funding round, which was led by the early-stage venture capitalist Innovestor.

Brinter Successfully Closes Seed Funding Round Led by Innovestor

Boehringer Ingelheim has joined the Quantum Technology and Application Consortium (QUTAC) as a founding member.

Boehringer Ingelheim Joins QUTAC as Founding Member

VIVEbiotech has opened its new lentiviral vector manufacturing facilities in Spain, expanding capacity for lentiviral vectors for use in cell and gene therapies.

Supplier News